Written by Donya Shabgard
Edited by Leanne Quong
Our world has a pandemic that is often silent and unacknowledged – the fight against addiction and post-traumatic stress disorder (PTSD). These afflictions carry with them a multitude of adverse effects, including depression, anxiety, and trauma. On a global scale, the number of individuals struggling with addiction disorders is staggering, with a reported 164 million affected in 2016 (Ritchie, 2018). Similarly, 350 million people worldwide have experienced PTSD (Doblin, 2020). These statistics testify to the magnitude of the problem and the importance of addressing it with urgency and compassion.
It is alarming to see the number of people facing addiction and PTSD, and the traditional therapy methods are not proving very effective. Shockingly, 85% of those who opt for conventional addiction treatment end up relapsing, while almost half of those with PTSD fail to recover through traditional methods (Sinha, 2013 & VA Research, n.d.). These figures indicate that we need a revolutionary solution to combat this widespread problem.
The NuMind Solution
At NuMind Health, we understand the potential benefits of psychedelic-assisted therapy in addressing various challenges. This therapy involves using specific drugs to enhance the treatment process and has been extensively researched since the 1950s. Our approach to psychedelic-assisted therapy is based on a comprehensive understanding of the interconnectedness between an individual’s physical, psychological, and spiritual aspects. We aim to empower individuals to heal and unlock their full potential through a bespoke approach that supports them long-term. Our treatments, which include government-approved Ibogaine and Methylenedioxymethamphetamine (MDMA), are targeted at helping individuals manage addiction, trauma, PTSD, depression, and anxiety. We operate within legally approved jurisdictions and adhere to strict treatment protocols to ensure sustainable wellness for our clients.
NuMind Health harnesses the therapeutic potential of Ibogaine to help individuals overcome mental and spiritual disconnections and lead fulfilling lives. Unlike traditional therapy methods, Ibogaine is a powerful addiction interrupter that effectively treats addiction and other mental health challenges when administered correctly. Our comprehensive program includes pre-care assessments, preparation, treatment, integration, and aftercare support services.
The effectiveness of Ibogaine as a treatment method has been demonstrated through studies conducted by pioneering researchers Dr. Deborah Mash and Mr. John Giordani. According to their findings, up to 50% of clients maintained sobriety post-treatment, compared to only 5% with traditional methods (Giordano & Mash, n.d.). This remarkable success rate is attributed to Ibogaine’s unique ability to reset neurochemistry, which results in long-lasting anti-addictive effects thanks to its metabolite, noribogaine.
NuMind understands that overcoming addiction and mental health challenges can be daunting. Therefore, we strive to provide a supportive, safe, and professional environment that enables individuals to receive the best possible care. Our team of experienced professionals is dedicated to ensuring that each person gets personalized care and support throughout their journey to recovery. Anyone can overcome challenges and achieve a fulfilling life with the proper care and support.
NuMind Health has also partnered with Dr. Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies (MAPS), to introduce MDMA-assisted psychotherapy. This therapy catalyzes overcoming PTSD and some challenges associated with PTSD. MDMA is an established entactogen known for its ability to enhance self-awareness and empathy. Reports suggest that it fosters closeness between clients and therapists, induces relaxation, boosts motivation to engage in therapy, and encourages reflective thinking.
Moreover, it alleviates depression and anxiety, enabling therapists to address underlying trauma without causing emotional distress. According to research by Dr. Doblin, approximately 67% of individuals no longer experienced PTSD twelve months post MDMA-assisted psychotherapy. Compared to traditional therapy, MDMA-assisted psychotherapy proves more effective as it fosters trust in the therapist and facilitates mental clarity, confidence, and the courage to introspect honestly, especially for those grappling with PTSD (Dolin, 2021).
Our Intention & Mission
At NuMind Health, our team of experts is driven by a passion for helping people transform their lives through the healing power of psychedelics. With full approval from the Bahamian Government, we are dedicated to being the trusted leaders in evidence-based psychedelic-assisted therapy. Our focus is enriching the lives of those struggling with addiction and other mental health challenges and empowering them to achieve sustainable wellness through compassionate, safe, and evidence-based psychedelic-assisted therapy. We are committed to forging a unique path in the industry that puts the needs of our clients first.
Seize the opportunity to transform your life and take control of your future today! Get all the details about our platform by visiting NuMindHealth.com.